2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.87% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.62% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.5% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.38% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.63% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.82% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.65% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
5.71% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
5.71% |
0% |
2024-10-18 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
5.71% |
0% |
2024-10-18 |
AXSM
Axsome Therapeutics, Inc.
|
Buy |
5.71% |
0% |
2024-10-18 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.75% |
0.35% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.83% |
-0.33% |
2024-10-17 |
The percentage of cash held in the portfolio is:
36.27%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AXSM |
Buy
All
|
-7.81% |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.14% |
5.52% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.53% |
-3.15% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.44% |
10.41% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
7.35% |
8.99% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.61% |
-1.95% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.72% |
-0.34% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
7% |
3.83% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.89% |
2.27% |
2024-10-16 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.64% |
1.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.84% |
-3.9% |
2024-10-07 |
BHVN
Biohaven Ltd.
|
Sell |
-3.75% |
0% |
2024-10-17 |
The percentage of cash held in the portfolio is:
55.55%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORMP |
Buy
All
|
-1.67% |
CUTR |
Buy
All
|
9.25% |
FATE |
Buy
All
|
0% |
IRWD |
Sell
All
|
5.63% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.57% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
7.1% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.73% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.83% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.99% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.79% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.82% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
6.81% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
6.81% |
0% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-3.42% |
8% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.53% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.66% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.58% |
4.11% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.73% |
0.18% |
2024-10-07 |
The percentage of cash held in the portfolio is:
56.47%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.45% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.9% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.79% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
6.85% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
6.85% |
0% |
2024-10-15 |
CUTR
Cutera, Inc.
|
Sell |
-3.54% |
5.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.55% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.72% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.47% |
7.61% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.7% |
1.35% |
2024-10-07 |
The percentage of cash held in the portfolio is:
70.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.43% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.88% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
6.87% |
0% |
2024-10-14 |
CUTR
Cutera, Inc.
|
Sell |
-3.8% |
-1.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.61% |
3.74% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.74% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.43% |
8.99% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.81% |
-1.12% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.21%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.34% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.75% |
-1.95% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.64% |
2.67% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.43% |
8.41% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.76% |
-0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.44% |
8.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.61% |
4.05% |
2024-10-07 |
The percentage of cash held in the portfolio is:
104.79%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.48% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.89% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.89% |
0% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.76% |
-0.31% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.68% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-3.76% |
0% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-3.76% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
98.45%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
6.43% |
0% |
2024-10-03 |
CUTR
Cutera, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-3.75% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
104.82%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-23 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
2.48% |
Assets Rebalanced
None
2024-09-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.19% |
4.89% |
2024-09-09 |
The percentage of cash held in the portfolio is:
92.81%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVCR |
Sell
All
|
-1.16% |
Assets Rebalanced
None
2024-09-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
6.7% |
-2.44% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.24% |
5.56% |
2024-09-09 |
The percentage of cash held in the portfolio is:
86.06%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CERS |
Buy
All
|
15.64% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
6.87% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.14% |
3.45% |
2024-09-09 |
CERS
Cerus Corporation
|
Sell |
-3.87% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
89.87%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.65% |
40.42% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
7.13% |
2.88% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.09% |
2.3% |
2024-09-09 |
CERS
Cerus Corporation
|
Sell |
-3.9% |
1.9% |
2024-09-05 |
The percentage of cash held in the portfolio is:
80.03%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
5.41% |
ESPR |
Sell
All
|
4.37% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MGNX
MacroGenics, Inc.
|
Buy |
9.47% |
3.13% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.73% |
-4.92% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.01% |
27.5% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
6.8% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
6.94% |
-2.56% |
2024-09-09 |
CERS
Cerus Corporation
|
Sell |
-3.97% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
63.02%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
2.22% |
LMAT |
Buy
All
|
2.57% |
AVXL |
Buy
All
|
12.76% |
PODD |
Sell
All
|
11.4% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.63% |
10.8% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.28% |
1.42% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.65% |
-5.46% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.42% |
33.75% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
6.65% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.11% |
0.26% |
2024-09-09 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.69% |
3.03% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.24% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.95% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.96% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
64.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
6.89% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
9.36% |
7.2% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.04% |
-1.71% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.54% |
-7.1% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.48% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
6.56% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.17% |
0.63% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.6% |
7.17% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.71% |
2.83% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.35% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-3.58% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.92% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
68.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
-0.8% |
PACB |
Buy
All
|
-22.96% |
SGMO |
Buy
All
|
-22.22% |
ALDX |
Sell
All
|
-6.49% |
AADI |
Sell
All
|
3.43% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.65% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.33% |
5.05% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.66% |
-7.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.43% |
-9.84% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
8.23% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.42% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
6.78% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
7.25% |
0% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-3.79% |
3.86% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.84% |
1.1% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.4% |
12.41% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.55% |
-17.04% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.28% |
0.24% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.11% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-3.99% |
4.27% |
2024-09-05 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.04% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
67.25%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
16.54% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.51% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.35% |
5.72% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.96% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.75% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.41% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.61% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
7.22% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.34% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.79% |
3.61% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.83% |
1.07% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.66% |
5.44% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-4.01% |
-3.7% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.26% |
0.1% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.24% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.09% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
74.41%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-6.41% |
AGEN |
Sell
All
|
-8.59% |
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.62% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.31% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.49% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
9.17% |
3.96% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.78% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.23% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.48% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
7.59% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.42% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.81% |
2.72% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.83% |
0.61% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.69% |
4.42% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.77% |
2.22% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.63% |
2024-09-02 |
VREX
Varex Imaging Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.13% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
70.33%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
APLS |
Sell
All
|
-5.21% |
ORGO |
Sell
All
|
-4.59% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.85% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.79% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.43% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.29% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
8.94% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.92% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
8.7% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.31% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.16% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.62% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.92% |
0.15% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
1.75% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.59% |
7.14% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.84% |
0.74% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.21% |
1.84% |
2024-09-02 |
The percentage of cash held in the portfolio is:
44.96%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-2.98% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.68% |
-2.4% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.92% |
1.77% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.11% |
4.96% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.48% |
-5.85% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.82% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6.34% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.92% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.5% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.47% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.02% |
0% |
2024-09-02 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.8% |
0.38% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.89% |
-2.22% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.92% |
-2.93% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.8% |
-1.4% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.84% |
-2.38% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.79% |
-1.23% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.8% |
-1.48% |
2024-08-29 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.17% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
47.08%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.58% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.04% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.44% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.78% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.89% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.75% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
8.57% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
8.57% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.68% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.75% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.82% |
-0.3% |
2024-08-28 |
LMAT
LeMaitre Vascular, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.75% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
PACB
Pacific Biosciences of California, Inc.
|
Sell |
-3.75% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
- LMAT
- AVXL
- VERU
- PACB
- PODD
- EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.62% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.98% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.02% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.92% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
5.91% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
5.82% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
6.82% |
0% |
2024-08-28 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.66% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-3.76% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-3.76% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
63.38%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.64% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
6.09% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.14% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.11% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
6% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
6% |
0% |
2024-08-27 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.65% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
61.99%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.71% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.93% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.81% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
6.07% |
6.03% |
2024-08-23 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-3.75% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
74.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.51% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.69% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.63% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
5.8% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
71.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
5.76% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
82.71%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-14 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Buy
All
|
22.42% |
EGRX |
Buy
All
|
15.82% |
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.55% |
28.25% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.06% |
13.71% |
2024-07-31 |
The percentage of cash held in the portfolio is:
105.61%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-4.91% |
Assets Rebalanced
None
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.2% |
-2.95% |
2024-07-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.68% |
24.66% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.11% |
12.45% |
2024-07-31 |
The percentage of cash held in the portfolio is:
99.58%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CPRX |
Buy
All
|
-6.15% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
5.88% |
-7.66% |
2024-07-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.48% |
30.04% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.18% |
10.34% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.62% |
5.86% |
2024-08-01 |
The percentage of cash held in the portfolio is:
103.39%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
INGN |
Buy
All
|
-20.7% |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.17% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
7.81% |
7.5% |
2024-07-31 |
INGN
Inogen, Inc.
|
Sell |
-3.25% |
6.97% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-2.67% |
23.77% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.39% |
2.95% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.62% |
4.47% |
2024-08-01 |
The percentage of cash held in the portfolio is:
98.96%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.38% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.23% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.2% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
5.75% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
5.93% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
7.71% |
3.13% |
2024-07-31 |
INGN
Inogen, Inc.
|
Sell |
-3.57% |
0.87% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.26% |
9.42% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.63% |
-0.84% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.83% |
1.8% |
2024-08-01 |
The percentage of cash held in the portfolio is:
72.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Buy
All
|
-1.17% |
RARE |
Buy
All
|
-3.2% |
NKTR |
Buy
All
|
5.93% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
6.7% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.28% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.66% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.46% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
6.09% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
7.67% |
2.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.69% |
0.31% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.89% |
-5.24% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.67% |
0.74% |
2024-07-19 |
INGN
Inogen, Inc.
|
Sell |
-3.63% |
-0.76% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.64% |
-0.9% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.66% |
-1.69% |
2024-07-31 |
CPRX
Catalyst Pharmaceuticals, Inc.
|
Sell |
-3.91% |
0% |
2024-08-01 |
The percentage of cash held in the portfolio is:
83.22%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Buy
All
|
-6.87% |
RCM |
Sell
All
|
-1.15% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
6.5% |
-1% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
6.72% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.42% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
7.8% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.51% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
6.27% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
7.65% |
0% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-3.75% |
0.6% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.95% |
-4.51% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.89% |
-2.96% |
2024-07-19 |
SMTI
Sanara MedTech Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
INGN
Inogen, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.68% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
78.46%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
6.32% |
-2.61% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.2% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
6.19% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
6.66% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.44% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
7.91% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.44% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
6.22% |
0% |
2024-07-30 |
PODD
Insulet Corporation
|
Sell |
-3.67% |
1.61% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.95% |
-5.75% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.76% |
-0.74% |
2024-07-19 |
The percentage of cash held in the portfolio is:
58%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Buy
All
|
-5.84% |
FATE |
Sell
All
|
39.07% |
VERU |
Sell
All
|
-1.22% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
7.27% |
39.85% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.19% |
-0.17% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.46% |
-0.19% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.21% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.62% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
6.53% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
6.53% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
6.53% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
6.53% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.53% |
0% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-3.69% |
0.85% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.91% |
-4.86% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.81% |
-2.22% |
2024-07-19 |
RMD
ResMed Inc.
|
Sell |
-3.72% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
47.72%
New Assets Added
- RMD
- SMTI
- CYH
- HQY
- SAVA
- SAGE
Assets Removed
Asset |
Action |
Perf % |
WAT |
Buy
All
|
-5.03% |
MASI |
Sell
All
|
-2.65% |
BKD |
Sell
All
|
8.27% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MASI
Masimo Corporation
|
Buy |
1.69% |
-1.95% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.82% |
5.96% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
7.2% |
38.82% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.18% |
-0.17% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.41% |
-0.84% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.45% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
7.49% |
0% |
2024-07-26 |
PODD
Insulet Corporation
|
Sell |
-3.64% |
2.09% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.92% |
-5.33% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.77% |
-1.48% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.78% |
-2.5% |
2024-07-22 |
The percentage of cash held in the portfolio is:
76.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
22.51% |
SGRY |
Sell
All
|
20.35% |
AVNS |
Sell
All
|
8.22% |
CUTR |
Sell
All
|
-5.41% |
RGNX |
Sell
All
|
13.22% |
SUPN |
Sell
All
|
7.69% |
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
7.21% |
19.58% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
7% |
16.16% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.43% |
6.7% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
5.86% |
-2.7% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.47% |
7.32% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.44% |
6.84% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.7% |
-2.4% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.85% |
6.23% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
6.98% |
33.16% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.23% |
-0.17% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.59% |
0.92% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.61% |
0% |
2024-07-25 |
PODD
Insulet Corporation
|
Sell |
-3.74% |
0.3% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.96% |
-5.45% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.92% |
-4.44% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.75% |
-0.86% |
2024-07-22 |
The percentage of cash held in the portfolio is:
45.03%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PDSB |
Sell
All
|
6.96% |
OPK |
Sell
All
|
7.58% |
SAGE |
Sell
All
|
-11.55% |
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.25% |
9.94% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.45% |
12.88% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.06% |
17.13% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.86% |
13.7% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.26% |
3.82% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.48% |
7.43% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
5.97% |
-1.02% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.32% |
4.73% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.4% |
6.18% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.66% |
-4.64% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.8% |
3.66% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.76% |
9.77% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
4.96% |
-5.42% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.66% |
2% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.76% |
-0.04% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.74% |
0.54% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.87% |
-2.96% |
2024-07-19 |
WAT
Waters Corporation
|
Sell |
-3.73% |
0% |
2024-07-22 |
The percentage of cash held in the portfolio is:
34.19%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
TDOC |
Sell
All
|
-2.99% |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.22% |
9.66% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
5.76% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.58% |
15.15% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.82% |
13.38% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
5.98% |
-0.64% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.85% |
13.89% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.37% |
5.95% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.3% |
4.73% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.08% |
1.1% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.24% |
3.71% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.15% |
2.14% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.67% |
-4.06% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.81% |
4.07% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.8% |
10.8% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.17% |
-1.22% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.42% |
-1.46% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-3.75% |
0% |
2024-07-19 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Sell |
-3.75% |
0% |
2024-07-19 |
NKTR
Nektar Therapeutics
|
Sell |
-3.75% |
0% |
2024-07-19 |
The percentage of cash held in the portfolio is:
19.03%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.26% |
13.92% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.38% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
6.86% |
7.58% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.72% |
-1.88% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
7.04% |
20.72% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.24% |
7.04% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.74% |
15.66% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.23% |
6.89% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.58% |
12.84% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.09% |
4.48% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.03% |
3.54% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
5.92% |
1.61% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.64% |
-2.67% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.76% |
4.74% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.81% |
14.65% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.38% |
6.14% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
6.31% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None
2024-07-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.99% |
20.03% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
7.07% |
6.27% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
7.03% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.21% |
8.33% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.84% |
-3.96% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
5.88% |
-3.26% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.01% |
-1.17% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.13% |
0.74% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.01% |
-1.18% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.33% |
4.05% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.16% |
1.26% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.12% |
0.55% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.13% |
0.84% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.71% |
-2.75% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.8% |
2.44% |
2024-07-15 |
FATE
Fate Therapeutics, Inc.
|
Buy |
5.29% |
0% |
2024-07-16 |
VERU
Veru Inc.
|
Buy |
5.29% |
0% |
2024-07-16 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
APLS |
Buy
All
|
-10.22% |
VRDN |
Sell
All
|
11.2% |
RYTM |
Sell
All
|
21.63% |
Assets Rebalanced
None
2024-07-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.86% |
5.15% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.64% |
17.23% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.81% |
16.19% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
7.08% |
5.28% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
7.1% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.03% |
4.55% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.96% |
-3.1% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.02% |
-2.12% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.16% |
0.21% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.47% |
5.17% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.12% |
-0.47% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.11% |
-0.68% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.18% |
0.47% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.16% |
0.21% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.18% |
0.46% |
2024-07-12 |
MASI
Masimo Corporation
|
Buy |
1.77% |
0% |
2024-07-15 |
BKD
Brookdale Senior Living Inc.
|
Buy |
1.77% |
0% |
2024-07-15 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.41% |
-8.93% |
2024-07-02 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SGMO |
Buy
All
|
-25% |
CDNA |
Buy
All
|
-10.41% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.49% |
-1.97% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.23% |
9.21% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.52% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
7.16% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
7.01% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
7.08% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
CUTR
Cutera, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
RGNX
REGENXBIO Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
SUPN
Supernus Pharmaceuticals, Inc.
|
Buy |
6.24% |
0% |
2024-07-12 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-4.86% |
-22.22% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.41% |
-7.16% |
2024-07-02 |
CDNA
CareDx, Inc
|
Sell |
-3.84% |
-9.44% |
2024-07-11 |
The percentage of cash held in the portfolio is:
14.48%
New Assets Added
- WST
- ANGO
- TDOC
- SGRY
- AVNS
- CUTR
- RGNX
- SAGE
- SUPN
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Buy
All
|
4.95% |
PAHC |
Buy
All
|
-6.77% |
CYH |
Sell
All
|
15.94% |
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.12% |
4.37% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.24% |
-7.12% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.99% |
4.01% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
6.93% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
6.93% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
6.93% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
6.93% |
0% |
2024-07-11 |
FGEN
FibroGen, Inc.
|
Sell |
-3.41% |
12.33% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-4.49% |
-11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.31% |
-3.17% |
2024-07-02 |
PAHC
Phibro Animal Health Corporation
|
Sell |
-3.56% |
0% |
2024-07-11 |
CDNA
CareDx, Inc
|
Sell |
-3.56% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
71.27%
New Assets Added
- PAHC
- CDNA
- PDSB
- BHVN
- ALT
- OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
7.01% |
3.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.22% |
-6.59% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.01% |
5.32% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-3.14% |
18.54% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.89% |
2.78% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.28% |
-3.44% |
2024-07-02 |
The percentage of cash held in the portfolio is:
91.07%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
6.02% |
NVRO |
Sell
All
|
-11.61% |
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.46% |
4.12% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.8% |
1.25% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.43% |
-2.79% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.17% |
-6.81% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.79% |
2.55% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-3.01% |
21.46% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.54% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.19% |
-1.98% |
2024-07-02 |
The percentage of cash held in the portfolio is:
78.09%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
-3.41% |
ACAD |
Sell
All
|
2.77% |
EGRX |
Sell
All
|
34.15% |
Assets Rebalanced
None
2024-07-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.82% |
-1.83% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.28% |
22.77% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.28% |
0.9% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.09% |
5.31% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.46% |
-2.67% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.15% |
-7.27% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.35% |
-4.36% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
6.86% |
3.41% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.58% |
32.91% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.55% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-4.02% |
2.42% |
2024-07-02 |
The percentage of cash held in the portfolio is:
57.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Sell
All
|
1.87% |
Assets Rebalanced
None
2024-07-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.88% |
-0.25% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.88% |
16.74% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.51% |
5.2% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.36% |
2.79% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
7.18% |
7.19% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
6.4% |
-3.02% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.08% |
-7.95% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.55% |
-0.77% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
7.13% |
7.95% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.76% |
27.86% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.53% |
11.11% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-3.96% |
3.61% |
2024-07-02 |
The percentage of cash held in the portfolio is:
51.25%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CHRS |
Sell
All
|
-19.65% |
MNKD |
Sell
All
|
-7.37% |
ARDX |
Sell
All
|
-28.74% |
Assets Rebalanced
None
2024-07-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.74% |
1.01% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.33% |
-6.26% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.02% |
23.44% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.69% |
12.05% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.16% |
3.19% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.7% |
3.75% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
6.95% |
2.16% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
6.33% |
-6.94% |
2024-07-01 |
NVRO
Nevro Corp.
|
Buy |
6.37% |
0% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
6.37% |
0% |
2024-07-02 |
FGEN
FibroGen, Inc.
|
Sell |
-2.75% |
25.24% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.51% |
8.33% |
2024-07-01 |
APLS
Apellis Pharmaceuticals, Inc.
|
Sell |
-3.96% |
0% |
2024-07-02 |
The percentage of cash held in the portfolio is:
33.83%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Buy
All
|
-8.17% |
MODV |
Buy
All
|
-8.11% |
Assets Rebalanced
None
2024-07-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.81% |
2.33% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.46% |
-3.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
7.09% |
25% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.7% |
12.5% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.15% |
3.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.77% |
5% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
6.79% |
0% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
6.79% |
0% |
2024-07-01 |
NVRO
Nevro Corp.
|
Sell |
-3.89% |
-5.78% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.82% |
-4.83% |
2024-06-27 |
FGEN
FibroGen, Inc.
|
Sell |
-3.18% |
13.4% |
2024-06-28 |
SGMO
Sangamo Therapeutics, Inc.
|
Sell |
-3.82% |
0% |
2024-07-01 |
The percentage of cash held in the portfolio is:
63.15%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.93% |
3.09% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.6% |
-2.58% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.44% |
12.05% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.67% |
10.52% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.28% |
3.94% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
6.54% |
0% |
2024-06-28 |
NVRO
Nevro Corp.
|
Sell |
-3.92% |
-5.03% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.73% |
-0.84% |
2024-06-27 |
FGEN
FibroGen, Inc.
|
Sell |
-3.73% |
0% |
2024-06-28 |
The percentage of cash held in the portfolio is:
73.9%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Buy
All
|
-12.3% |
Assets Rebalanced
None
2024-06-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.64% |
-2.39% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.52% |
-4.42% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
6.35% |
9.82% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.52% |
7.54% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.17% |
1.71% |
2024-06-26 |
NVRO
Nevro Corp.
|
Sell |
-4.01% |
-7.16% |
2024-06-26 |
MODV
ModivCare Inc.
|
Sell |
-3.71% |
0% |
2024-06-27 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-3.71% |
0% |
2024-06-27 |
The percentage of cash held in the portfolio is:
81.24%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Sell
All
|
-12.08% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.68% |
-1.76% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.58% |
-3.5% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
5.64% |
-2.5% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.88% |
1.56% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
6.07% |
0% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
6.07% |
0% |
2024-06-26 |
NVRO
Nevro Corp.
|
Sell |
-3.75% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
68.82%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
5.76% |
0% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
5.76% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
76.94%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-06 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SLP |
Buy
All
|
5.86% |
Assets Rebalanced
None
2024-06-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SLP
Simulations Plus, Inc.
|
Sell |
-4.63% |
9.52% |
2024-05-23 |
The percentage of cash held in the portfolio is:
104.63%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
7.35% |
Assets Rebalanced
None
2024-06-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BGNE
BeiGene, Ltd.
|
Sell |
-2.98% |
12.64% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-4.7% |
7.98% |
2024-05-23 |
The percentage of cash held in the portfolio is:
107.68%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
GERN |
Buy
All
|
-9.74% |
Assets Rebalanced
None
2024-06-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BGNE
BeiGene, Ltd.
|
Sell |
-3.03% |
11.08% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-4.93% |
3.48% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.35% |
-1.72% |
2024-05-24 |
The percentage of cash held in the portfolio is:
112.31%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ICUI |
Buy
All
|
-2.26% |
Assets Rebalanced
None
2024-05-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ICUI
ICU Medical, Inc.
|
Sell |
-4.07% |
2.74% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.07% |
9.62% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-4.94% |
2.88% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.05% |
4.87% |
2024-05-24 |
The percentage of cash held in the portfolio is:
116.12%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Buy
All
|
-12.87% |
SGMO |
Sell
All
|
-12.31% |
RCM |
Sell
All
|
3.04% |
BCRX |
Sell
All
|
-3.3% |
Assets Rebalanced
None
2024-05-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
6.37% |
2% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.07% |
-2.67% |
2024-05-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.58% |
-4.62% |
2024-05-20 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.2% |
-0.88% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.65% |
-11.55% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.1% |
8.53% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-5.04% |
0.46% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.07% |
4.01% |
2024-05-24 |
The percentage of cash held in the portfolio is:
100.04%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
10.3% |
VKTX |
Buy
All
|
5.36% |
BLFS |
Sell
All
|
-1.34% |
Assets Rebalanced
None
2024-05-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.47% |
-3.17% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
6.23% |
-0.16% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.01% |
-3.62% |
2024-05-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.29% |
-7.69% |
2024-05-20 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.54% |
9.14% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.07% |
2.22% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.23% |
-1.65% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.09% |
8.77% |
2024-05-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-2.89% |
14.42% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-5.05% |
0.3% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.23% |
0.29% |
2024-05-24 |
The percentage of cash held in the portfolio is:
99.1%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Sell
All
|
NA |
EDIT |
Sell
All
|
NA |
PACB |
Sell
All
|
NA |
Assets Rebalanced
None
2024-05-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.45% |
0.25% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.33% |
-1.4% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.2% |
-3.11% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.47% |
-3.17% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
6.23% |
-0.16% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.01% |
-3.62% |
2024-05-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.29% |
-7.69% |
2024-05-20 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.54% |
9.14% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.07% |
2.22% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.23% |
-1.65% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.09% |
8.77% |
2024-05-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-2.89% |
14.42% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-5.05% |
0.3% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.23% |
0.29% |
2024-05-24 |
The percentage of cash held in the portfolio is:
77.12%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGRY |
Buy
All
|
4.51% |
CARA |
Sell
All
|
-16.65% |
Assets Rebalanced
None
2024-05-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.66% |
4.51% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.48% |
2.1% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.37% |
0.52% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.15% |
-5.97% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
5.97% |
-2.92% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.12% |
-0.47% |
2024-05-16 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.53% |
-8.82% |
2024-05-17 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.45% |
-4.62% |
2024-05-20 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.05% |
8.09% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.43% |
10.85% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.12% |
-0.29% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.3% |
-4.62% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.11% |
6.7% |
2024-05-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-2.85% |
14.65% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-4.96% |
0.62% |
2024-05-23 |
GERN
Geron Corporation
|
Sell |
-4.18% |
0% |
2024-05-24 |
The percentage of cash held in the portfolio is:
73.27%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Buy
All
|
12.58% |
GERN |
Sell
All
|
-10.51% |
VCYT |
Sell
All
|
-7.38% |
Assets Rebalanced
None
2024-05-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
6.95% |
-3.91% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
8.15% |
12.78% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.62% |
5.43% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
6.93% |
-4.15% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.32% |
-2.45% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
5.9% |
-2.72% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.36% |
4.72% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.7% |
-6.15% |
2024-05-16 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.76% |
-4.35% |
2024-05-17 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.61% |
-1.54% |
2024-05-20 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.83% |
8.7% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.11% |
5.27% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.46% |
8.76% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.11% |
-1.55% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.39% |
-8.25% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.3% |
-0.32% |
2024-05-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-2.87% |
12.81% |
2024-05-22 |
SLP
Simulations Plus, Inc.
|
Sell |
-4.93% |
0% |
2024-05-23 |
The percentage of cash held in the portfolio is:
59.71%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BKD |
Buy
All
|
3.14% |
PODD |
Sell
All
|
-2.32% |
Assets Rebalanced
None
2024-05-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
7.16% |
-3.2% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
8.07% |
9.02% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.14% |
-3.5% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.01% |
-5.18% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.42% |
-3.34% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
6.1% |
-1.76% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.27% |
0.94% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.89% |
-5.13% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
7.13% |
-1.4% |
2024-05-17 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.77% |
-6.34% |
2024-05-17 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.26% |
-7.69% |
2024-05-20 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.85% |
1.57% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-3.98% |
7.4% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.21% |
4.48% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.61% |
6.99% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.1% |
1.2% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.52% |
-9.08% |
2024-05-20 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.37% |
0% |
2024-05-22 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.37% |
0% |
2024-05-22 |
The percentage of cash held in the portfolio is:
52.78%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MDRX |
Buy
All
|
-2.53% |
ILMN |
Buy
All
|
4.62% |
Assets Rebalanced
None
2024-05-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
7.3% |
-0.89% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
8.17% |
11.03% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.12% |
-3.33% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.32% |
-0.52% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.44% |
-2.67% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
6.05% |
-2.08% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
5.96% |
-3.62% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.91% |
-4.36% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
7.15% |
-0.67% |
2024-05-17 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.7% |
-6.83% |
2024-05-17 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.36% |
-6.15% |
2024-05-20 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.92% |
-3.2% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.65% |
3.8% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.82% |
2% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.16% |
2.73% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.2% |
4.21% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.78% |
2.24% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.1% |
0.72% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.2% |
-1.82% |
2024-05-20 |
The percentage of cash held in the portfolio is:
53.35%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Sell
All
|
-5.82% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
7.3% |
1.69% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
8.18% |
14.04% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.06% |
-1.58% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.51% |
4.66% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.29% |
-2.1% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
5.99% |
-0.56% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
5.95% |
-1.26% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.88% |
-2.31% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
7.08% |
1.02% |
2024-05-17 |
NVRO
Nevro Corp.
|
Buy |
7.15% |
2.06% |
2024-05-17 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.53% |
-6.83% |
2024-05-17 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
8.68% |
0% |
2024-05-20 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.72% |
-0.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.64% |
1.55% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.75% |
1.29% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.03% |
3.31% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.16% |
2.86% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.65% |
2.98% |
2024-05-17 |
ICUI
ICU Medical, Inc.
|
Sell |
-4.02% |
0% |
2024-05-20 |
TVTX
Travere Therapeutics, Inc.
|
Sell |
-4.02% |
0% |
2024-05-20 |
The percentage of cash held in the portfolio is:
45.39%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Sell
All
|
4.74% |
AORT |
Sell
All
|
12.09% |
OMCL |
Sell
All
|
1.03% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NUTX
Nutex Health Inc.
|
Buy |
8.29% |
8.41% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.68% |
12.28% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.28% |
5.08% |
2024-05-06 |
VCYT
Veracyte, Inc.
|
Buy |
7.37% |
4% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.99% |
12.78% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.31% |
3.15% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
8.04% |
13.47% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.2% |
-2.05% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
5.86% |
-1.52% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
6.05% |
1.73% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.95% |
0% |
2024-05-16 |
PODD
Insulet Corporation
|
Buy |
6.92% |
0% |
2024-05-17 |
NVRO
Nevro Corp.
|
Buy |
6.92% |
0% |
2024-05-17 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.92% |
0% |
2024-05-17 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.82% |
-4.53% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.71% |
-1.45% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.78% |
-1% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.33% |
-5.18% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.2% |
0.53% |
2024-05-13 |
VKTX
Viking Therapeutics, Inc.
|
Sell |
-3.72% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
22.77%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BGNE |
Buy
All
|
-5.46% |
ALT |
Sell
All
|
23.78% |
GKOS |
Sell
All
|
5.12% |
KIDS |
Sell
All
|
-0.06% |
MD |
Sell
All
|
-8.68% |
Assets Rebalanced
None
2024-05-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ALT
Altimmune, Inc.
|
Buy |
9.02% |
23.37% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.28% |
6.06% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.79% |
-1.38% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
8.05% |
5.62% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.73% |
13.38% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
6.84% |
-0.86% |
2024-05-06 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
6.79% |
-3.87% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
7.39% |
4.67% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.94% |
12.53% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.42% |
5.08% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.86% |
11.4% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.51% |
2.5% |
2024-05-15 |
RCM
R1 RCM Inc.
|
Buy |
5.93% |
0% |
2024-05-16 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
5.93% |
0% |
2024-05-16 |
GERN
Geron Corporation
|
Buy |
5.93% |
0% |
2024-05-16 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.64% |
0.13% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.71% |
-1.94% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.8% |
-1.71% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.21% |
-2.59% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.26% |
-1.81% |
2024-05-13 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.63% |
-1.67% |
2024-05-14 |
The percentage of cash held in the portfolio is:
13.85%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FOLD |
Buy
All
|
-4.66% |
ARWR |
Buy
All
|
-13.51% |
INGN |
Sell
All
|
25.39% |
SGMO |
Sell
All
|
7.41% |
RYTM |
Sell
All
|
-4.42% |
ACRS |
Sell
All
|
-6.35% |
WST |
Sell
All
|
-4.6% |
Assets Rebalanced
None
2024-05-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
9.3% |
26.52% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.76% |
5.56% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.54% |
-2.53% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.64% |
-6.35% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.04% |
8.76% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.34% |
5.66% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.42% |
-3.79% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.86% |
-1.54% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
8.05% |
4.44% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.73% |
11.99% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.01% |
0.5% |
2024-05-06 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
7.1% |
-0.59% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
7.31% |
2.31% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.72% |
8.02% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.11% |
-0.53% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
8.25% |
15.54% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
7.42% |
0% |
2024-05-15 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.68% |
0.13% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.78% |
-2.45% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.86% |
-2.14% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.38% |
-5.46% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.29% |
-1.39% |
2024-05-13 |
FOLD
Amicus Therapeutics, Inc.
|
Sell |
-3.28% |
-1.08% |
2024-05-13 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.59% |
0.86% |
2024-05-14 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Sell |
-3.76% |
-3.85% |
2024-05-14 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SENS |
Sell
All
|
0.62% |
Assets Rebalanced
None
2024-05-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.99% |
-8.83% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.49% |
25.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.73% |
1.85% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.74% |
-2.97% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.81% |
-6.35% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.82% |
2.5% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.39% |
3.17% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.73% |
-2.79% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.03% |
-2.14% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
8.18% |
2.82% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.89% |
10.85% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.36% |
2.22% |
2024-05-06 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
7.37% |
0% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
7.37% |
0% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
7.37% |
0% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
7.37% |
0% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
7.37% |
0% |
2024-05-14 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.91% |
-2.8% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.8% |
0.04% |
2024-05-08 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.89% |
0.14% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.41% |
-3.09% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.25% |
2.67% |
2024-05-13 |
FOLD
Amicus Therapeutics, Inc.
|
Sell |
-3.27% |
2.06% |
2024-05-13 |
BGNE
BeiGene, Ltd.
|
Sell |
-3.73% |
0% |
2024-05-14 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Sell |
-3.73% |
0% |
2024-05-14 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- BGNE
- ARWR
- MD
- VCYT
- AVXL
- EDIT
- PACB
Assets Removed
Asset |
Action |
Perf % |
MD |
Buy
All
|
-0.35% |
ALGN |
Buy
All
|
10.52% |
IBRX |
Sell
All
|
-4% |
CARA |
Sell
All
|
-0.79% |
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IBRX
ImmunityBio, Inc.
|
Buy |
7.57% |
-9.68% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.93% |
-5.29% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.45% |
-4.31% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.25% |
20% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.99% |
3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.65% |
-5.53% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.85% |
-7.14% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.78% |
0.42% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.66% |
5.17% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.99% |
-1.16% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.13% |
-2.26% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
7.5% |
-7.18% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
8.13% |
12.42% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.31% |
-0.03% |
2024-05-06 |
ALGN
Align Technology, Inc.
|
Sell |
-3.26% |
10.87% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-4.01% |
-3.73% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.78% |
2.03% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.83% |
3.29% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.99% |
-0.86% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.34% |
0.07% |
2024-05-10 |
SGRY
Surgery Partners, Inc.
|
Sell |
-3.39% |
0% |
2024-05-13 |
FOLD
Amicus Therapeutics, Inc.
|
Sell |
-3.39% |
0% |
2024-05-13 |
The percentage of cash held in the portfolio is:
23.82%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Buy
All
|
13.52% |
ITGR |
Buy
All
|
-4.01% |
PTCT |
Sell
All
|
12.88% |
IOVA |
Sell
All
|
-12.24% |
Assets Rebalanced
None
2024-05-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.09% |
8.68% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.33% |
-10.34% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.18% |
0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.5% |
-1.23% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.27% |
23.26% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.24% |
-3.7% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.93% |
7.6% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.35% |
-7.07% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.98% |
-2.78% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
8.12% |
7.37% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.28% |
2.47% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.82% |
-0.78% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.5% |
5.28% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
7.66% |
-2.91% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.89% |
11.8% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.17% |
0.4% |
2024-05-06 |
NVRO
Nevro Corp.
|
Sell |
-3.39% |
7.16% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.81% |
-4.24% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.28% |
8.01% |
2024-04-30 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.89% |
-3.2% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.72% |
1.3% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.71% |
3.88% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.96% |
-2.43% |
2024-05-09 |
VRDN
Viridian Therapeutics, Inc.
|
Sell |
-4.24% |
0% |
2024-05-10 |
The percentage of cash held in the portfolio is:
8.71%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ACHC |
Buy
All
|
-6.61% |
CDMO |
Sell
All
|
7.67% |
Assets Rebalanced
None
2024-05-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.23% |
9% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.3% |
-11.9% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.17% |
10.85% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.02% |
-3.04% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.53% |
-2.26% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
8.91% |
16.88% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.06% |
-7.41% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
8% |
7.12% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.53% |
-6.06% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.04% |
-3.17% |
2024-05-02 |
ALT
Altimmune, Inc.
|
Buy |
7.63% |
-0.42% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.33% |
1.79% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.96% |
-0.49% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
7.53% |
4.31% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
7.61% |
-4.82% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.96% |
11.32% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.2% |
-0.56% |
2024-05-06 |
NVRO
Nevro Corp.
|
Sell |
-3.32% |
10.25% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.82% |
-3.25% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.25% |
10.23% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-4.16% |
0.09% |
2024-05-06 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.87% |
-1.33% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.75% |
1.95% |
2024-05-08 |
MD
Pediatrix Medical Group, Inc.
|
Sell |
-3.92% |
0% |
2024-05-09 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.92% |
0% |
2024-05-09 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
Asset |
Action |
Weight |
WST |
Buy |
0.33% |
PTCT |
Buy |
0.37% |
IOVA |
Buy |
0.58% |
KIDS |
Buy |
1.06% |
RYTM |
Buy |
1.14% |
SENS |
Buy |
1.27% |
CARA |
Buy |
0.95% |
2024-05-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.18% |
11.27% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.49% |
-8.12% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.36% |
15.87% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.45% |
4.76% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.47% |
2.87% |
2024-05-01 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.49% |
0% |
2024-05-02 |
INGN
Inogen, Inc.
|
Buy |
7.76% |
3.55% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
6.35% |
-5.02% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.13% |
11.84% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.52% |
6.35% |
2024-05-02 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.65% |
9.09% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
7.62% |
1.11% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.28% |
2.81% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.11% |
-0.03% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
7.04% |
-10.41% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.15% |
0.56% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.98% |
13.57% |
2024-05-06 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.76% |
-3.25% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.71% |
-1.86% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.34% |
6% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-4.17% |
-1.98% |
2024-05-06 |
MDRX
Allscripts Healthcare Solutions, Inc.
|
Sell |
-3.76% |
0% |
2024-05-08 |
ILMN
Illumina, Inc.
|
Sell |
-3.76% |
0% |
2024-05-08 |
The percentage of cash held in the portfolio is:
1.44%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Buy
All
|
-6.93% |
EGRX |
Buy
All
|
-17.28% |
Assets Rebalanced
None
2024-05-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.47% |
15.37% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.1% |
-13.13% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.1% |
11.38% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
6.45% |
4.5% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
6.53% |
3.49% |
2024-05-01 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.38% |
-1.85% |
2024-05-02 |
INGN
Inogen, Inc.
|
Buy |
7.67% |
1.99% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.1% |
5.91% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.1% |
11.04% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
6.39% |
3.97% |
2024-05-02 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.46% |
5.63% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
7.74% |
2.36% |
2024-05-03 |
GKOS
Glaukos Corporation
|
Buy |
7.1% |
-0.02% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.1% |
-0.52% |
2024-05-03 |
NUTX
Nutex Health Inc.
|
Buy |
7.8% |
-1% |
2024-05-06 |
OMCL
Omnicell, Inc.
|
Buy |
7.1% |
-0.5% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.1% |
0.67% |
2024-05-06 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.78% |
-3.62% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.72% |
-1.96% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.6% |
1.5% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.36% |
5.72% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-4.02% |
-12.84% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-4.2% |
-2.51% |
2024-05-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ATRI |
Buy
All
|
-10.12% |
Assets Rebalanced
Asset |
Action |
Weight |
CARA |
Sell |
-1.06% |
SENS |
Sell |
-1.25% |
ACRS |
Sell |
-1.42% |
OMCL |
Sell |
-0.74% |
AORT |
Sell |
-0.84% |
RYTM |
Sell |
-0.86% |
CDMO |
Sell |
-0.9% |
IOVA |
Sell |
-1.25% |
ALT |
Buy |
0.84% |
IBRX |
Buy |
0.86% |
GKOS |
Buy |
0.98% |
WST |
Buy |
1.01% |
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.36% |
15.54% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.2% |
1.78% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.72% |
9.13% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.28% |
2.94% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.68% |
3.68% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
7.51% |
1.42% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.99% |
7.94% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
8.07% |
9.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.62% |
2.93% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.82% |
5.62% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
6.11% |
1.41% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
5.97% |
-0.93% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.22% |
3.21% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
6.12% |
1.53% |
2024-05-03 |
OMCL
Omnicell, Inc.
|
Buy |
7.76% |
0% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
7.76% |
0% |
2024-05-06 |
AORT
Artivion, Inc.
|
Buy |
7.76% |
0% |
2024-05-06 |
ATRI
Atrion Corporation
|
Sell |
-3.78% |
-5.05% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.59% |
0.27% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.65% |
-1.54% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.76% |
-4.7% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.32% |
5.56% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.82% |
-8.89% |
2024-04-30 |
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-4.04% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMMT |
Sell
All
|
13.73% |
Assets Rebalanced
None
2024-05-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.69% |
17.68% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
6.87% |
5.18% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.23% |
-0.22% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.86% |
8.47% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.4% |
2.12% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
8.07% |
6.37% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
7.56% |
-0.28% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.89% |
3.97% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.82% |
3.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.3% |
-3.7% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.5% |
-1.09% |
2024-05-02 |
GKOS
Glaukos Corporation
|
Buy |
6.17% |
0% |
2024-05-03 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
6.17% |
0% |
2024-05-03 |
KIDS
OrthoPediatrics Corp.
|
Buy |
6.17% |
0% |
2024-05-03 |
ALT
Altimmune, Inc.
|
Buy |
6.17% |
0% |
2024-05-03 |
ATRI
Atrion Corporation
|
Sell |
-3.87% |
-5.05% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.63% |
1.5% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.7% |
-0.31% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.76% |
-1.92% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.38% |
6% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.91% |
-8.64% |
2024-04-30 |
The percentage of cash held in the portfolio is:
14.35%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ALT |
Buy
All
|
-12.43% |
GKOS |
Buy
All
|
-9.41% |
Assets Rebalanced
None
2024-05-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.81% |
19.57% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
7.96% |
21.76% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.89% |
-5.01% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.36% |
1.46% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.28% |
0.4% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.22% |
-4.93% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
7.59% |
0% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
7.59% |
0% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
7.59% |
0% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
7.59% |
0% |
2024-05-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
7.59% |
0% |
2024-05-02 |
ATRI
Atrion Corporation
|
Sell |
-3.98% |
-8.07% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.39% |
8.04% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.69% |
-0.18% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.7% |
-0.31% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.36% |
6.66% |
2024-04-30 |
ALT
Altimmune, Inc.
|
Sell |
-3.98% |
-10.56% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.72% |
-3.46% |
2024-04-30 |
GKOS
Glaukos Corporation
|
Sell |
-4.18% |
-3.03% |
2024-05-01 |
The percentage of cash held in the portfolio is:
47.54%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.46% |
12.53% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
6.75% |
1.81% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
6.54% |
-11.12% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.43% |
0.93% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.32% |
-0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
7.71% |
0% |
2024-05-01 |
ATRI
Atrion Corporation
|
Sell |
-4.01% |
-7.16% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.5% |
6.54% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.81% |
-1.87% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.75% |
-0.08% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.39% |
7.36% |
2024-04-30 |
ALT
Altimmune, Inc.
|
Sell |
-3.74% |
-2.42% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.69% |
-0.99% |
2024-04-30 |
GKOS
Glaukos Corporation
|
Sell |
-4.12% |
0% |
2024-05-01 |
The percentage of cash held in the portfolio is:
86.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.45% |
12.5% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
6.66% |
0.52% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
7.35% |
0% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
7.35% |
0% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
7.35% |
0% |
2024-04-30 |
ATRI
Atrion Corporation
|
Sell |
-3.97% |
-6.33% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.77% |
-0.88% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.91% |
-4.55% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.76% |
-0.77% |
2024-04-29 |
ALGN
Align Technology, Inc.
|
Sell |
-3.65% |
0% |
2024-04-30 |
ALT
Altimmune, Inc.
|
Sell |
-3.65% |
0% |
2024-04-30 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-3.65% |
0% |
2024-04-30 |
The percentage of cash held in the portfolio is:
90.2%
New Assets Added
- ALGN
- ALT
- EGRX
- IBRX
- CDMO
- CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
6.65% |
0% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
6.65% |
0% |
2024-04-29 |
ATRI
Atrion Corporation
|
Sell |
-3.75% |
0% |
2024-04-29 |
NVRO
Nevro Corp.
|
Sell |
-3.75% |
0% |
2024-04-29 |
ITGR
Integer Holdings Corporation
|
Sell |
-3.75% |
0% |
2024-04-29 |
OFIX
Orthofix Medical Inc.
|
Sell |
-3.75% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
101.71%
New Assets Added
- ATRI
- NVRO
- ITGR
- OFIX
- PTCT
- SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-25 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Buy
All
|
31.35% |
BKD |
Buy
All
|
-1.35% |
FATE |
Buy
All
|
31.42% |
Assets Rebalanced
None
2024-04-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NUTX
Nutex Health Inc.
|
Sell |
-1.78% |
45.39% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.09% |
5.11% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-2.93% |
10.05% |
2024-04-11 |
The percentage of cash held in the portfolio is:
107.8%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
-6.11% |
Assets Rebalanced
None
2024-04-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.83% |
-1.53% |
2024-04-02 |
NUTX
Nutex Health Inc.
|
Sell |
-2.54% |
22.54% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.27% |
0.15% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.11% |
5.1% |
2024-04-11 |
The percentage of cash held in the portfolio is:
98.08%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
UTHR |
Buy
All
|
-3.27% |
RVNC |
Sell
All
|
-9.76% |
Assets Rebalanced
None
2024-04-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.54% |
-10.37% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
10.79% |
-3.05% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-6.81% |
-3.51% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-3.31% |
0% |
2024-04-11 |
BKD
Brookdale Senior Living Inc.
|
Sell |
-3.31% |
0% |
2024-04-11 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-3.31% |
0% |
2024-04-11 |
The percentage of cash held in the portfolio is:
96.42%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
20.18% |
TNDM |
Sell
All
|
-2.07% |
KIDS |
Sell
All
|
9.67% |
ACRS |
Sell
All
|
-7.94% |
LXRX |
Sell
All
|
-15.83% |
Assets Rebalanced
None
2024-04-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
12.12% |
22.28% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.79% |
-1.16% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
10.4% |
4.94% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.36% |
-5.56% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.96% |
-4.67% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.01% |
-13.75% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
11.51% |
5.34% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-6.67% |
-3.19% |
2024-03-29 |
The percentage of cash held in the portfolio is:
34.52%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Buy
All
|
-1111.05% |
Assets Rebalanced
None
2024-04-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
6.41% |
8.6% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
5.61% |
-5.1% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.44% |
-7.9% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.72% |
-3.17% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
5.71% |
-8.33% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
5.73% |
-7.92% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
6.71% |
3.05% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-3.83% |
0.5% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-3.73% |
1.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
66.23%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-5.57% |
Assets Rebalanced
None
2024-04-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
6% |
2.28% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
5.62% |
-4.11% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
5.71% |
-2.69% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
5.86% |
0% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
5.84% |
-0.37% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
5.94% |
-3.86% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
5.87% |
-5% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
6.47% |
0% |
2024-04-02 |
UTHR
United Therapeutics Corporation
|
Sell |
-3.8% |
0.64% |
2024-03-29 |
NUTX
Nutex Health Inc.
|
Sell |
-3.74% |
0% |
2024-04-02 |
The percentage of cash held in the portfolio is:
60.22%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Sell
All
|
-3.17% |
ATRI |
Sell
All
|
-11.81% |
Assets Rebalanced
None